Debt to EBITDA ratio Analysis of Aridis Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of ARDS
Dec-22-0.146Very Poor Debt to EBITDA | Dec-21-0.139Very Poor Debt to EBITDA | Growth-5.16% |
Debt to EBITDA Analysis of Aridis Pharmaceuticals Inc
| Debt to EBITDA Ratio of ARDS has fallen by -5.16 % Compared to previous Financial Year. |
| Debt to EBITDA Ratio with value of 0.0227 was highest in Year Dec-20 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.146 was lowest in Year Dec-22 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.146 is lower than Average Debt to EBITDA of -0.076 in last five years. |
Other Debt to EBITDA Related Info of ARDS that may interest you.
Aridis Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ARDS | 0.06 | 0.0625 | 4.00 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Poor Stability Stock | |
FY - Historical Debt to EBITDA of Aridis Pharmaceuticals Inc
| Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.146 | -0.139 | 0.0227 | 0 | -0.116 | 0 | 0 |
| Change | -5.16 % | -712.57 % | 0 % | 0 % |
FY Chart of Debt to EBITDA of Aridis Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)